News | Hepatitis Central - Part 92

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Research & Treatment News

New Technology and Methods to Fight Hepatitis C

Aug 6, 2007

Recent technology has allowed researchers to safely and effectively kill blood-borne diseases. In July 2007, researchers announced favorable results in Ultraviolet Blood Irradiation (UBI) outside the body. Discover what scientists have to say about using this new method to fight Hepatitis C and AIDS.

Continue reading »

The Skinny on Fatty Liver Disease

Aug 6, 2007

Visceral fat, or "internal flab" associated with fatty liver disease, is manifesting into a big liver problem. Learn about fatty liver disease, lifestyle factors that may increase the likelihood of developing this liver condition, as well as why being thin does not guarantee having a healthy liver.

Continue reading »

Rare Liver Transplant with Child is Successful

Jul 27, 2007

Last month, doctors at Children's Hospital of Pittsburgh performed a domino transplant, a rare liver transplant operation, on a 9 year-old boy. Learn more about this successful operation, as well as what a domino transplant is and why it's so rare.

Continue reading »

Bishop of Athens to Undergo Liver Transplant

Jul 25, 2007

Millions of people worldwide are affected with hepatitis infections and, as people who are familiar with hepatitis know, the disease can affect anyone. After recovering from his intestinal cancer operation, it has been recommended to Orthodox Archbishop Christodoulos of Athens that he undergo a liver transplant because of his end-stage liver disease, chronic hepatitis and cirrhosis. Learn more about the liver transplant set to take place, as well as what the risks are for the surgery.

Continue reading »

Getting Easier: Predicting Hepatitis C Treatment Success

Jul 16, 2007

Just released by Veteran Affairs, new research has identified several factors to help predict Hepatitis C treatment success. In addition to race, cholesterol level, the presence of cirrhosis and ALT enzyme elevation, this report also suggests that specific viral genotypes respond best to different types of pegylated interferon.

Continue reading »